RecallDepth
Class II Terminated

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
April 7, 2022
Posted
April 27, 2022
Recall Number
D-0774-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
33,893 vials
Firm Location
Morgantown, WV, United States

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls